AFM Study of Nanoscale Membrane Perturbation Induced by Antimicrobial Lipopeptide C14 KYR

Sawinee Nasompag1, Pawinee Siritongsuk2, Saengrawee Thammawithan2

  • 1Interdisciplinary Graduate Program in Genetic Engineering, The Graduate School, Kasetsart University, Bangkok 10900, Thailand.

Membranes
|July 2, 2021
PubMed

Insights

The lipopeptide C14-KYR severely disrupts E. coli membranes, causing shrinkage and leakage. Atomic Force Microscopy (AFM) quantified these nanoscale effects, revealing significant surface changes and increased cell rupture force.

Area of Science:

  • Microbiology
  • Biophysics
  • Materials Science

Background:

  • Lipopeptides are investigated as antimicrobial agents.
  • The C14-KYR lipopeptide is a modified KYR tripeptide with myristic acid.

Purpose of the Study:

  • To compare the membrane perturbation of live E. coli by KYR and C14-KYR lipopeptides.
  • To elucidate the nanoscale surface disruption mechanism of C14-KYR using AFM.

Main Methods:

  • Atomic Force Microscopy (AFM) imaging for nanoscale analysis.
  • AFM force spectroscopy to measure cell adhesion and rupture forces.
  • Synchrotron radiation FTIR microspectroscopy (SR-FTIR) to analyze membrane structural changes.

Main Results:

  • C14-KYR caused severe surface disruption, including membrane shrinkage and cytosolic leakage.
  • AFM revealed increased cell roughness from 129.2 nm to 223.5 nm after C14-KYR treatment.
  • The rupture force of C14-KYR treated cells was four times higher than untreated cells (0.16 nN).

Conclusions:

  • C14-KYR exhibits a potent membrane disruption mechanism against E. coli.
  • AFM is effective in quantifying lipopeptide-induced bacterial cell damage at the nanoscale.
  • This study provides mechanistic insights into lipopeptide antimicrobial action.

Related Concept Videos